Unlocking Lung Cancer Treatment: New Insights into HER2 and PD-L1
Recent studies shed light on promising treatments targeting HER2 mutations and the effectiveness of PD-L1 IHC assays in lung cancer, offering hope for more personalized and effective therapies.